Proteome based analysis of circulating SARS-CoV-2 variants: approach to a universal vaccine candidate
Description
The discovery of the first infectious variant in Wuhan, China, in December 2019, has posed concerns over global health due to the spread of COVID-19 and subsequent variants. While the majority of patients experience flu-like symptoms such as cold and
